Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to the CONDUCT study team for completing recruitment.

© Shutterstock

One in 10 women see their GP each year because they have a urinary tract infection (UTI), and may be asked to provide a urine sample. Up to 30% of these samples are contaminated by bacterial which normally live on the body, making it difficult to get an accurate diagnosis.

The CONDUCT study is comparing the effectiveness of two different urine collection devices, which are designed to reduce the possibility of contamination - the Whizaway Midstream and the Peezy. Both are funnel shaped containers and use two different methods to collect the sample.

Recruitment is now complete, with 1264 women taking part recruited through 55 GP practices across England and Wales. The study is managed by a team in the Primary Care Clinical Trials Unit and led by Dr Gail Hayward, Deputy Director of the NIHR Community Healthcare MedTech and In Vitro Diagnostics Co-operative.

The study is funded by the NIHR Research for Patient Benefit Programme.


Contact our communications team

Opinions expressed are those of the authors and not of Oxford University. Readers' comments will be moderated - see our guidelines for further information.

CONDUCT study team: